title: Clinical approach and management for selected fungal infections in pulmonary and critical care patients.
abstract: Fungal lung infections are widely encountered and present both diagnostic and therapeutic challenges. The increasing prevalence of fungal infections is correlated with increasing numbers of immunocompromised patients, enhanced awareness of these infections, and improved methodologies for diagnosis. Fortunately, additional antifungal agents are available to combat these important infections. This review covers the clinical approach to fungal lung infections encountered in pulmonary and critical care practice.
authors.affiliation: Thoracic Diseases Research Unit and the Division of Pulmonary and Critical Medicine, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN. Electronic address: limper.andrew@mayo.edu.
authors.forename: Andrew H
authors.initials: AH
authors.lastname: Limper
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003422:Critical Care / Q000379:methods; D016638:Critical Illness / Q000628:therapy; D019468:Disease Management; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy*; D011379:Prognosis; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents